Organoid10.51335/organoid.2021.1.e820211e8Disease modeling and drug screening using human airway organoids: a systematic reviewDo Hyun Kim, Sung Won Kim,,
Drug Discovery Today: Technologies10.1016/j.ddtec.2012.12.0052013101e73-e81Modeling colorectal cancer as a 3-dimensional disease in a dish: the case for drug screening using organoids, zebrafish, and fruit fliesMichele Markstein,
Drug Metabolism and Pharmacokinetics10.1016/j.dmpk.2020.04.2932020351S7S2.2 - Kidney organoids for disease modeling and high throughput screeningBenjamin Freedman,
Current Progress in iPSC Disease Modeling10.1016/b978-0-323-85765-9.00003-52022275-296Modeling heritable kidney disease using human kidney iPSC-derived organoidsThomas A. Forbes, Melissa H. Little,
International Journal of Molecular Sciences10.3390/ijms21176215202021176215iPSC-Derived Liver Organoids: A Journey from Drug Screening, to Disease Modeling, Arriving to Regenerative MedicineCristina Olgasi, Alessia Cucci, Antonia Follenzi
Drug Discovery Today10.1016/j.drudis.2019.11.0102020252456-465CNS organoids: an innovative tool for neurological disease modeling and drug neurotoxicity screeningTanya Chhibber, Sounak Bagchi, Behnaz Lahooti, Angela Verma, Abraham Al-Ahmad, Manash K. Paul, Gurudutt Pendyala, Rahul Dev Jayant,
Organoids10.3390/organoids101000420221137-40Organoids, Assembloids and Embryoids: New Avenues for Developmental Biology, Disease Modeling, Drug Testing and Toxicity Assessment without Animal ExperimentationSüleyman Ergün, Philipp Wörsdörfer
10.21203/ nervous system tumors with human stem cells and organoidsYuan Wang, Jie Duan,
Acta Pharmacologica Sinica10.1038/aps.2013.632013346755-764Disease modeling and drug screening for neurological diseases using human induced pluripotent stem cellsXiao-hong Xu, Zhong Zhong,,
International Journal of Molecular Sciences10.3390/ijms190409362018194936Disease Modeling Using 3D Organoids Derived from Human Induced Pluripotent Stem CellsBeatrice Ho, Nicole Pek, Boon-Seng Soh